[en] BACKGROUND: Human papilloma viruses (HPV) are responsible for a variety of proliferative epithelial lesions including anogenital condylomas. These lesions may regress during treatment with an immune-response modifier such as imiquimod. The release of specific cytokines from the monocyte-macrophage lineage induces a cascade of events abating the HPV replication. METHOD: A total of 14 persistent warty anogenital lesions were excised 4 to 7 weeks after completing a 4-month imiquimod treatment. Another series of 25 untreated condylomas and 8 bowenoid papulosis served as controls. All examined lesions had been excised in otherwise healthy individuals with a normal immune status. Lesions were examined for the presence of Langerhans cells and subpopulations of the monocyte/macrophage/dendrocyte lineage using immunohistochemical detection of L1-protein, CD68, lysozyme and Factor-XIIIa. CD45R0-positive T lymphocytes were also identified. HPV capsid antigens and genotypes were searched for using immunohistochemistry and in situ hybridization, respectively. RESULTS: The persistent although treated anogenital lesions were identified as 10 viral condylomas, 3 bowenoid papulosis and 1 basal cell carcinoma. The inflammatory cell densities and distributions were similar in the untreated and imiquimod-resistant condylomas with the exception of Factor XIIIa-positive dendrocytes. These dermal dendritic cells were slim and rare in all imiquimod-resistant lesions. In contrast, about two-thirds of the untreated condylomas were enriched in these cells. CONCLUSION: As dermal dendritic cells play a role in the immune surveillance, their low densities in some lesions might be a key feature responsible for low cytokine local production and failure of imiquimod treatment. The combined apparent lack of Langerhans cell activation might suggest that both intraepidermal and intradermal compartments of antigen-presenting cells are affected in imiquimod-resistant lesions.
Disciplines :
Dermatology
Author, co-author :
Arrese, J.
Paquet, Philippe ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Koutsky L.A., Galloway D.A., Holmes K.K. (1988) Epidemiology of genital human papillomavirus infection. Epidemiol Rev 10:122.
Heaton C.L. (1995) Clinical manifestations and modern management of condylomata acuminata: A dermatologic perspective. Am J Obstet Gynecol 172:1344.
Stone K.M. (1995) Human papillomavirus infection and genital warts: Update on epidemiology and treatment. Clin Infect Dis 20.
Ferenczy A. (1995) Epidemiology and clinical pathophysiology of condylomata acuminata. Am J Obstet Gynecol 172:1331.
Drake L.A., Ceilley R.I., Cornelison R.L. (1995) Guidelines of care for warts: Human papillomavirus. J Am Acad Dermatol 32:98.
Laimins L.A. (1993) The biology of human papillomaviruses: From warts to cancer. Infect Agents Dis 2:74.
Delvenne P., Fontaine M.A., Delvenne C., Nikkels A., Boniver J. (1994) Detection of human papillomaviruses in paraffin-embedded biopsies of cervical intraepithelial lesions. Analysis by immunohistochemistry, in situ hybridization and the polymerase chain reaction. Mod Pathol 7:113.
Coleman N., Birley H.D.L., Renton A.M. (1994) Immunological events in regressing genital warts. Am J Clin Pathol 102:768.
Stanley M. (1998) The immunology of genital human papilloma virus infection. Eur J Dermatol 8:82.
Phelps W.C., Alexander K.A. (1995) Anti-viral therapy for human papillomaviruses: Rationale and prospects. Ann Intern Med 123:368.
Eron L.J., Judson F., Tucker S. (1986) Interferon therapy for condylomata acuminata. N Engl J Med 315:1059.
Reichman R.C., Oakes D., Bonnez W. (1988) Treatment of condyloma acuminatum with three different interferons administered intralesionally: A double-blind, placebo-controlled trial. Ann Intern Med 108:675.
Delvenne P., Al-Saleh W., Gilles C., Thiry A., Boniver J. (1995) Inhibition of growth of normal and human papillomavirus-transformed keratinocytes in monolayer and organotypic cultures by interferon gamma and tumor necrosis factor alpha. Am J Pathol 146:589.
Tornai M.A., Birmachu W., Case M.T. (1997) Imiquimod in vivo and in vitro characteristics and toxicology., Aly R, Beutner KR, Maibach H, eds. Cutaneous infection and therapy. New York: Marcel Dekker; 405.
Edwards L., Ferenczy A., Eron L. (1998) Self-administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol 134:25.
Tyring S.K., Arany I., Stanley M.A. (1998) A randomised, controlled, molecular study of condyloma acuminata clearance during treatment with imiquimod. J Infect Dis 178:551.
Beutner K.R., Geisse J.K., Helman D., Fox T.L., Ginkel A., Owens M.L. (1999) Therapeutic response of basal cell carcioma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol 41:1002.
Kono T., Kondo S., Pastore S. (1994) Effects of a novel topical immunomodulator, imiquimod, on keratinocyte cytokine gene expression. Lymphokine Cytokine Res 13:71.
Megyeri K., Au W.C., Rosztoczy I. (1995) Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by Sendai virus utilise similar signal transduction pathways. Mol Cell Biol 15:2207.
Miller R., Birmachu W., Gerster J. (1995) Imiquimod: Cytokine induction and anti-viral activity. Int Anti-viral News 3:111.
Testerman T.L., Gerster J.F., Imbertson L.M. (1995) Cytokine induction by the immunomodulators imiquimod and S-27609. J Leukoc Biol 58:365.
Slade H.B. (1998) Cytokine induction and modifying the immune respons to human papilloma virus with imiquimod. Eur J Dermatol 8:13.
Arrese J.E., Piérard G.E. (1990) Factor XIIIa-positive dendrocytes and the dermal microvascular unit. Dermatologica 180:51.
Nestle F.O., Zheng X.G., Thompson G.B., Turka L.A., Nickoloff B.J. (1993) Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J Immunol 151:6535.
Nestle F.O., Nickoloff B.J. (1995) A fresh morphological and functional look at dermal dendritic cells. J Cutan Pathol 22:385.
Kharfi M., Mokhtar L., Fazaa B. (1992) Vulvar basal cell carcinoma. Eur J Dermatol 2:81.
Al-Saleh W., Delvenne P., Arrese J.E., Nikkels A.F., Piérard G.E., Boniver J. (1995) Inverse modulation of intraepithelial Langerhans' cells and stromal macrophage/dendrocyte populations in human papillomavirus-associated squamous intraepithelial lesions of the cervix. Virchows Arch 427:41.
Piérard-Franchimont C., Arrese J.E., Nikkels A.F., Al-Saleh W., Delvenne P., Piérard G.E. (1996) Factor XIIIa-positive dermal dendrocytes and proliferative activity of cutaneous cancers. Virchows Arch 429:43.
Aiba S., Rokugo M., Tagami H. (1986) Immunohistologic analysis of the phenomenon of spontaneous regression of numerous flat warts. Cancer 58:1246.
Ierlbeck G., Schiebel U., Muller C. (1989) Immunohistology of genital warts in different stages of regression after therapy with interferon gamma. Dermatologica 179:191.
Henriksson P., Becker S., Lynch G., McDonagh J. (1985) Identification of intracellular factor XIIIa in human monocytes and macrophages. J Clin Invest 76:528.
Piérard G.E., Nikkels-Tassoudji N., Arrese J.E., Nikkels A.F., Piérard-Franchimont C. (1998) L1-protein in incipient lymphocyte-depleted graft-versus-host disease. Expression in keratinocytes and coexpression with Factor XIIIa in dermal cells. Turk J Dermatopathol 7:10.
Piérard-Franchimont C., Arrese Estrada J., Nikkels A., Ben Mosbah T., Deleixhe-Mauhin F., Piérard G.E. (1990) Dendrocytes et cellules dendritiques épidermiques au cours du photovieillissement. Ann Dermatol Venereol 117:965.
Piérard G.E., Piérard-Franchimont C., Hermanns-Lê T., Arrese Estrada J. (1992) Factor XIIIa-positive dendritic cells in mycosis fungoides. Cancer J 5:226.
Paquet P., Piérard G.E. (1997) Erythema multiforme and toxic epidermal necrolysis. A comparative study. Am J Dermatopathol 19:127.